Mohamed (Mo) Alhamar, MD
@mo_alhamar
@HenryFordHealth | @MSKPathology | @WCMCPathology |
ID: 1008876480
13-12-2012 14:01:40
446 Tweet
643 Followers
825 Following
Just published! Congrats to @Moe_Alhamar Sean R Williamson MD Kiril_T_Can and colleagues amazing study! Histopathology Gene Fusion Characterization of Rare Aggressive #ProstateCancer #Variants pubmed.ncbi.nlm.nih.gov/32639612/ #gupath #genomics #molpath #moldx
Check out our latest publication: Prognosis of HER2 FISH categories in breast cancer patients treated with HER2-targeted agents Modern Pathology #Breast #BreastPath doi.org/10.1038/s41379…
Lab-Clinician Partnerships: Why Collaboration Matters. Learn how Mohammed Israil has created the formal infastructure to connect clinicians and lab professionals: capatholo.gy/3dasxjA.
MSK Department of Pathology & Laboratory Medicine Welcome breakfast 2021. Great start to a great year. #breastpath
The International Journal of Surgical Pathology (IJSP) is now on Twitter! Looking forward to engage with readers, authors, and reviewers via this platform! #IJSPjournal Sean R Williamson MD
Presented at #USCAP23: Urine cytology remains a reliable screening & dx test for detecting intradiverticular bladder cancer (BC), with sensitivity similar to that for detecting extradiverticular BC. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Mohamed (Mo) Alhamar, MD Hikmat Al Ahmadie CC: Michiya Nishino, MD, PhD #CytoPath
Primary well-differentiated neuroendocrine/carcinoid tumors of prostate are exceedingly rare, yet recognized by the WHO classification #gupath #endopath Mohamed (Mo) Alhamar, MD et al report an incidentally detected WDNT in a man who underwent RP for #prostatecancer pubmed.ncbi.nlm.nih.gov/38303155/